Skip to main content

Lumos Pharma, Inc.

LUMODelisted Dec 12, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001126234

Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.

13F holders, Q1 2024

Institutional positions in Lumos Pharma, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
36
0 vs. Q4 2023
Shares held
2.18M
−190.9K (−8.1%) vs. Q4 2023
Total value
$6.14M
−$1.38M (−18.4%) vs. Q4 2023
New holders
2
8 more added
Sold out
2
7 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LUMO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 36 institutions
Q1 2021: 41 institutionsQ2 2021: 40 institutionsQ3 2021: 37 institutionsQ4 2021: 38 institutionsQ1 2022: 36 institutionsQ2 2022: 36 institutionsQ3 2022: 35 institutionsQ4 2022: 38 institutionsQ1 2023: 37 institutionsQ2 2023: 35 institutionsQ3 2023: 34 institutionsQ4 2023: 37 institutionsQ1 2024: 36 institutionsQ2 2024: 36 institutionsQ3 2024: 29 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2024: $6.14M
Q1 2021: $38.8MQ2 2021: $32.1MQ3 2021: $27.3MQ4 2021: $18.7MQ1 2022: $23.3MQ2 2022: $18.7MQ3 2022: $23.0MQ4 2022: $8.51MQ1 2023: $7.40MQ2 2023: $7.90MQ3 2023: $8.05MQ4 2023: $7.52MQ1 2024: $6.14MQ2 2024: $4.82MQ3 2024: $8.08MQ4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding LUMO and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 202429$8.08M
Q2 202436$4.82M
Q1 202436$6.14M
Q4 202337$7.52M
Q3 202334$8.05M
Q2 202335$7.90M
Q1 202337$7.40M
Q4 202238$8.51M
Q3 202235$23.0M
Q2 202236$18.7M
Q1 202236$23.3M
Q4 202138$18.7M
Q3 202137$27.3M
Q2 202140$32.1M
Q1 202141$38.8M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Lumos Pharma, Inc.; share changes are against Q4 2023.

Institutions holding LUMO in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Wells Fargo & Company415,551$1.17M0.00%−1,500−0.4%Reduced
Goldman Sachs Group Inc406,612$1.15M0.00%+10.0%Added
Vanguard Group Inc244,082$688.3K0.00%00.0%Unchanged
Renaissance Technologies LLC218,014$615.0K0.00%−3,600−1.6%Reduced
Acuitas Investments, LLC140,689$396.7K0.20%+15,407+12.3%Added
Jefferies Financial Group Inc.120,651$340.2K0.01%00.0%Unchanged
Lion Point Capital, LP90,794$256.0K0.49%00.0%Unchanged
Blackstone Group Inc.78,624$221.7K0.00%−247,928−75.9%Reduced
Greenwich Wealth Management LLC76,341$215.0K0.02%00.0%Unchanged
Geode Capital Management, LLC47,596$134.2K0.00%00.0%Unchanged
BlackRock Inc.41,104$115.9K0.00%−2,356−5.4%Reduced
Two Sigma Investments, LP38,817$109.5K0.00%−3,802−8.9%Reduced
Millennium Management LLC37,579$106.0K0.00%+37,579New
Two Sigma Advisers, LP31,900$90.0K0.00%+3,600+12.7%Added
Dimensional Fund Advisors LP29,617$83.5K0.00%+14,053+90.3%Added
Bridgeway Capital Management, LLC27,643$78.0K0.00%−20,000−42.0%Reduced
Marquette Asset Management, LLC25,760$72.6K0.01%00.0%Unchanged
Envestnet Asset Management Inc16,115$45.4K0.00%+4,173+34.9%Added
Private Advisor Group, LLC16,013$45.2K0.00%00.0%Unchanged
Citadel Advisors LLC13,286$37.5K0.00%+13,286New
Bank of New York Mellon Corp11,858$33.4K0.00%00.0%Unchanged
Wealth Advisors of Iowa, LLC11,699$33.0K0.02%00.0%Unchanged
State Street Corp11,237$31.7K0.00%00.0%Unchanged
Key Financial Inc10,927$30.8K0.01%00.0%Unchanged
Paladin Advisory Group, LLC4,387$12.5K0.01%00.0%Unchanged
UBS Group AG3,733$10.5K0.00%+3,659+4,944.6%Added
Tower Research Capital LLC (TRC)2,691$7.59K0.00%+1,117+71.0%Added
Bank of America Corp1,800$5.08K0.00%00.0%Unchanged
West Financial Advisors, LLC784$2.21K0.00%00.0%Unchanged
Morgan Stanley166$4680.00%00.0%Unchanged
Advisor Group Holdings, Inc.154$4350.00%−4,456−96.7%Reduced
Group One Trading, L.P.150$4230.00%00.0%Unchanged
JPMorgan Chase & Co41$1160.00%+3+7.9%Added
Global Retirement Partners, LLC11$310.00%00.0%Unchanged
Qube Research & Technologies Ltd3$80.00%00.0%Unchanged
Royal Bank of Canada78$00.00%00.0%Unchanged
Cypress Capital Management LLC (WY)0$00.00%−100−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−41−100.0%Sold out
Live Oak Investment Partners––––Not filed